Published in Ann Neurol on August 01, 2008
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage (2008) 3.74
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci (2015) 2.31
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05
Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain (2010) 2.04
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat (2009) 1.69
Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol (2013) 1.52
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry (2009) 1.44
Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol (2009) 1.42
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol (2010) 1.32
Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol (2010) 1.29
A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging (2011) 1.27
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol (2013) 1.25
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol (2013) 1.19
Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc (2011) 1.18
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis (2009) 1.15
Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2012) 1.15
Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther (2014) 1.11
Update on the pharmacological treatment of Alzheimer's disease. Curr Neuropharmacol (2010) 1.07
Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03
Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol (2011) 1.03
A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging (2013) 1.02
Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med (2014) 1.00
Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging (2013) 1.00
Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry (2010) 0.95
Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther (2015) 0.87
Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Mol Psychiatry (2015) 0.87
Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis (2015) 0.87
Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer's disease. PLoS One (2012) 0.86
Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging (2015) 0.85
A culture-brain link: Negative age stereotypes predict Alzheimer's disease biomarkers. Psychol Aging (2015) 0.84
Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci (2015) 0.83
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol (2016) 0.83
Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort. Alzheimers Dement (2012) 0.82
Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes. Neurobiol Aging (2015) 0.81
Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology (2014) 0.81
Transient Cerebral Ischemia Promotes Brain Mitochondrial Dysfunction and Exacerbates Cognitive Impairments in Young 5xFAD Mice. PLoS One (2015) 0.81
Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol (2014) 0.80
Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study. Alzheimers Dement (2016) 0.79
Objective measures of physical activity, white matter integrity and cognitive status in adults over age 80. Behav Brain Res (2015) 0.78
Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci (2013) 0.78
AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol (2012) 0.77
The multiple mechanisms of amyloid deposition: the role of parkin. Prion (2009) 0.77
Neuroregeneration and dementia: new treatment options. J Mol Psychiatry (2013) 0.77
Clinical-pathologic correlations in vascular cognitive impairment and dementia. Biochim Biophys Acta (2015) 0.76
Atrial fibrillation, cognitive impairment, and neuroimaging. Alzheimers Dement (2015) 0.76
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran. Neurol Sci (2016) 0.76
Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers. Brain Imaging Behav (2016) 0.75
Midlife and Late-Life Cardiorespiratory Fitness and Brain Volume Changes in Late Adulthood: Results From the Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci (2015) 0.75
Population-based analysis of pathological correlates of dementia in the oldest old. Ann Clin Transl Neurol (2017) 0.75
Genome instability in Alzheimer disease. Mech Ageing Dev (2016) 0.75
Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology. J Am Geriatr Soc (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr (1997) 4.87
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol (1986) 3.09
Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol (2000) 3.05
Atherosclerosis and risk for dementia. Ann Neurol (2007) 2.97
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology (2005) 2.76
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology (2006) 2.48
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry (2002) 1.88
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66
Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50
Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. J Am Geriatr Soc (2004) 1.28
Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke (2005) 1.26
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol (2000) 1.15
The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin North Am (2004) 1.02
Histologic assessment of the age of recent brain infarcts in man. J Neuropathol Exp Neurol (1993) 0.97
Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects. Stroke (2004) 0.95
Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology (2003) 0.93
Stroke risk factors and loss of high cognitive function. Neurology (2004) 0.92
[Prevalence and incidence of dementia in Denmark. The Odense study]. Ugeskr Laeger (2000) 0.82
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med (2003) 14.40
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet (2006) 8.19
Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci (2003) 7.26
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science (2004) 4.97
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med (2003) 4.67
Hearing loss and incident dementia. Arch Neurol (2011) 4.65
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. Am J Respir Crit Care Med (2004) 3.45
Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging (2006) 3.26
AGEMAP: a gene expression database for aging in mice. PLoS Genet (2007) 3.22
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc (2008) 3.21
Morphological classification of brains via high-dimensional shape transformations and machine learning methods. Neuroimage (2004) 3.13
Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage (2008) 2.93
Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke (2007) 2.75
Simple paradigm for extra-cerebral tissue removal: algorithm and analysis. Neuroimage (2011) 2.69
Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene (2003) 2.69
Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol (2006) 2.68
Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med (2012) 2.58
Hearing loss and cognition in the Baltimore Longitudinal Study of Aging. Neuropsychology (2011) 2.54
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci U S A (2005) 2.45
Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet (2007) 2.44
Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension (2007) 2.42
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology (2010) 2.40
Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology (2010) 2.39
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci (2012) 2.35
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31
Factorial invariance of the CES-D in low socioeconomic status African Americans compared with a nationally representative sample. Psychiatry Res (2004) 2.28
Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke (2009) 2.28
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Personality predictors of longevity: activity, emotional stability, and conscientiousness. Psychosom Med (2008) 2.19
Hormone therapy and risk of Alzheimer disease: a critical time. JAMA (2002) 2.16
Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci (2005) 2.06
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain (2010) 2.04
Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. J Neurosci (2012) 1.95
Intimate partner violence against adult women and its association with major depressive disorder, depressive symptoms and postpartum depression: a systematic review and meta-analysis. Soc Sci Med (2012) 1.94
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93
microRNA expression patterns reveal differential expression of target genes with age. PLoS One (2010) 1.92
Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension (2005) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A (2010) 1.81
Recruitment and retention strategies for minority or poor clinical research participants: lessons from the Healthy Aging in Neighborhoods of Diversity across the Life Span study. Gerontologist (2011) 1.78
Personality and obesity across the adult life span. J Pers Soc Psychol (2011) 1.75
Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PLoS Genet (2011) 1.75
Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol (2005) 1.74
Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73
Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab (2002) 1.70
Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis (2010) 1.68
Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage (2007) 1.67
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons? Clin Infect Dis (2004) 1.64
Differential association of concurrent, baseline, and average depressive symptoms with cognitive decline in older adults. Am J Geriatr Psychiatry (2008) 1.63
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet (2011) 1.60
Personality traits and chronic disease: implications for adult personality development. J Gerontol B Psychol Sci Soc Sci (2013) 1.60
Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol (2005) 1.58
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Hum Mol Genet (2005) 1.58
Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. Neuron (2003) 1.58
Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet (2007) 1.56
Intima-media thickness and regional cerebral blood flow in older adults. Stroke (2009) 1.56
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol (2009) 1.54
Genome-wide association studies of the PR interval in African Americans. PLoS Genet (2011) 1.53
A meta-analysis and genome-wide association study of platelet count and mean platelet volume in african americans. PLoS Genet (2012) 1.53
Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage (2002) 1.50
Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study. J Psychiatry Neurosci (2009) 1.49
Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.49
Longitudinal changes in cortical thickness associated with normal aging. Neuroimage (2010) 1.49
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Effects of age on virtual environment place navigation and allocentric cognitive mapping. Behav Neurosci (2002) 1.47
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Age stereotypes held earlier in life predict cardiovascular events in later life. Psychol Sci (2009) 1.45
The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y). Brain Res (2013) 1.44
Cross-sectional and longitudinal analyses of anatomical sulcal changes associated with aging. Cereb Cortex (2005) 1.43
Cortical surface segmentation and mapping. Neuroimage (2004) 1.42
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol (2011) 1.40
Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol (2015) 1.40
The trajectory of depressive symptoms across the adult life span. JAMA Psychiatry (2013) 1.39
Longitudinal changes in verbal memory in older adults: distinguishing the effects of age from repeat testing. Neurology (2003) 1.38